Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Shanghai Pharmaceuticals Holding Co Ltd    601607   CNE000000C82

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Shanghai Pharmaceuticals : to Buy Cardinal Health's Unit for US$557 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/15/2017 | 02:16am CET
   By Joanne Chiu 
 

Shanghai Pharmaceuticals Holding Co. (2607.HK) plans to buy the pharmaceutical distribution network of U.S. company Cardinal Health Inc. in Hong Kong and mainland China for US$557 million.

The Hong Kong listed pharmaceutical company said Wednesday that it has agreed to buy the entire interest in Cardinal Health's unit -Cardinal Health (L) Co. in a bid to broaden the coverage of its distribution network in China and build up direct-to-pharmacy chain with specialty brands.

Cardinal Health (L) Co. operates 14 direct sales companies and 17 distribution and operation centres in China with a total storage area of around 146,000 square meters and around 7,000 square meters cold storage capacity, it said.

Write to Joanne Chiu at [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHANGHAI PHARMACEUTICALS H
11/18 SHANGHAI PHARMACEUTICALS : Citi lowers Shanghai Pharma to HK$25.5
11/17 SHANGHAI PHARMACEUTICALS : buys out Cardinal Health in China to become top distr..
11/15 SHANGHAI PHARMACEUTICALS : ·discloseable transaction
11/15DJCARDINAL HEALTH : Pulls Back From China
11/15 SHANGHAI PHARMACEUTICALS : Pharma buys U.S. Cardinal Health's China business for..
11/15DJSHANGHAI PHARMACEUTICALS : to Buy Cardinal Health's Unit for US$557 Million
11/02 SHANGHAI PHARMACEUTICALS : ·Monthly Return of Equity Issuer on Movements in Secu..
10/31 SHANGHAI PHARMACEUTICALS : ·proposed amendments to the articles of association a..
10/30 SHANGHAI PHARMACEUTICALS : Realized Stable Results In the Third Quarter
10/20 SHANGHAI PHARMACEUTICALS : SH Pharma confirms bids for Cardinal's PRC business
More news
News from SeekingAlpha
11/15 Cardinal Health sells China business for $1.2B
07/30 WEEK IN REVIEW : Vivace Details Its Capital Efficient Plan To Develop Novel Canc..
2015 WEEK IN REVIEW : Hepalink Pharma Buys U.S.-Based CMO Cytovance
2015 WEEK IN REVIEW : Porton Fine Chemicals Buys Dongbang Pharma
Financials ( CNY)
Sales 2017 135 B
EBIT 2017 4 943 M
Net income 2017 3 545 M
Debt 2017 2 220 M
Yield 2017 1,41%
P/E ratio 2017 19,49
P/E ratio 2018 17,17
EV / Sales 2017 0,48x
EV / Sales 2018 0,42x
Capitalization 62 383 M
Chart SHANGHAI PHARMACEUTICALS H
Duration : Period :
Shanghai Pharmaceuticals H Technical Analysis Chart | 601607 | CNE000000C82 | 4-Traders
Technical analysis trends SHANGHAI PHARMACEUTICALS H
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 25,8  CNY
Spread / Average Target -0,16%
EPS Revisions
Managers
NameTitle
Min Zuo President & Executive Director
Jun Zhou Chairman
You Li Xu Chairman-Supervisory Board
Bo Shen Chief Financial Officer, Director & Vice President
Xin Chen Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SHANGHAI PHARMACEUTICALS HOLDING CO LTD32.31%9 406
SINOPHARM HOLDING CO LTD-0.31%11 270
TSURUHA HOLDINGS INC.29.91%6 283
SUNDRUG CO LTD22.62%5 921
COSMOS PHARMACEUTICAL CORP16.05%4 447
SUGI HOLDINGS CO.,LTD.6.47%3 332